NDT Biotech
PrivateLast Round
Debt
Jun 1, 2016
Total Funding Raised
$3.3M
Company Overview
NDT Biotech is a biotechnology company focused on developing nanoparticle-based therapies for the treatment of melanoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NDT Biotech Comparables
Compare NDT Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vitanova Biomedical | 77% | |
| Sona Nanotech | 77% | |
| Nanospectra Biosciences | 70% |
NDT Biotech Funding Rounds
Historical fundraising activity
NDT Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CincyTech | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2016
$1M debt round completed.
- Jul 29, 2011
$2.3M round led by CincyTech.
NDT Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NDT Biotech's valuation, stock price, and market status.
Is NDT Biotech a public or private company?
NDT Biotech is a private company.
What is the current stock price of NDT Biotech?
NDT Biotech is a private company, so its shares have no public market price. Caplight tracks NDT Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NDT Biotech worth (valuation)?
Valuation information for NDT Biotech is not publicly available.
Can I buy NDT Biotech stock?
NDT Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NDT Biotech's last funding round?
NDT Biotech's most recent funding round was Debt on June 1, 2016.
Who are the main investors in NDT Biotech?
Key investors in NDT Biotech include CincyTech.
Will NDT Biotech IPO soon?
No public IPO plans have been announced for NDT Biotech.
How can I track NDT Biotech secondary market activity?
Caplight tracks bids, offers, and trades in NDT Biotech's shares on secondary markets.